2670
The day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused.
 he: Subject; he: Subject.Gender; behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused: Effect; day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d: Treatment; clozapine: Treatment.Drug; clomipramine: Treatment.Drug; 150 mg/d: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 he: Subject; he: Subject.Gender; behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and confused: Effect; day after clozapine was stopped, while he was still receiving clomipramine 150 mg/d: Treatment; clozapine: Treatment.Drug; clomipramine: Treatment.Drug; 150 mg/d: Treatment.Dosage